Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon Region

Journal of Infectious Diseases

Volumn 196, Issue 6, 2007, Pages 844-852

  De Souza, Vanda A U F ^a   Sumita, Laura M ^a   Nascimento, Maria Claudia ^a,b   Oliveira, Juliane ^a   Mascheretti, Melissa ^a   Quiroga, Mariana ^a   Freire, Wilton S ^a   Tateno, Adriana ^a   Boulos, Marcos ^a   Mayaud, Philippe ^c   Pannuti, Claudio S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AMERICAN INDIAN; ARTICLE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; SEXUAL TRANSMISSION; SYPHILIS; VIRUS DETECTION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; BRAZIL; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INDIANS, SOUTH AMERICAN; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; RURAL POPULATION; SALIVA; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; VIRUS SHEDDING;

EID: 34548509193     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520549     Document Type: Article

References (50)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001; 356:517-34.
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332:1186-91.
4. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86:1276-80.
5. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95:1406-12.
6. Beral V, Peterman TA, Berkelman R, Jaffe HW. Kaposi's sarcoma among patients with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123-8.
7. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948-54.
8. O'Brien TR, Kedes D, Ganem D, et al. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999; 180:1010-7.
9. Blackbourn DJ, Osmond D, Levy JA, Lenette ET. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. J Infect Dis 1999; 179:237-9.
10. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2:925-8.
11. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8.
12. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1998; 1:207-13.
13. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998; 90:395-7.
14. Whitby D, Luppi M, Sabin C, et al. Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer 2000; 82:702-4.
15. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77:817-20.
16. de-Thé G, Bestetti G, van Beveren M, Gessain A. Prevalence of human herpesvirus 8 infection before the acquired immuno-deficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst 1999; 91:1888-9.
17. Rezza G, Tchangmena OB, Andreoni M, et al. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 2000; 27:159-64.
18. Newton R, Ziegler J, Bourboulia D, et al. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer 2003; 103:226-32.
19. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000; 181:1562-8.
20. Whitby D, Marshall VA, Bagni RK, et al. Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 2004; 85:155-63.
21. Cunha AMG, Caterino-de-Araujo A, Costa SCB, et al. Increasing seroprevalence of human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 2005; 86:2433-7.
22. Kazanji M, Dussart P, Duprez R, et al. Serological and molecular evidence that human herpesvirus 8 is endemic among Amerindians in French Guiana. J Infect Dis 2005; 192:1525-9.
23. Mohanna S, Maco V, Gown A, Morales D, Bravo F, Gotuzzo E. Is classic Kaposi's sarcoma endemic in Peru? Report of a case in an indigenous patient. Am J Trop Med Hyg 2006; 75:324-6.
24. Plancoulaine S, Abel L, van Beveren M, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000; 356:1062-5.
25. Andreoni M, el-Sawaf G, Rezza G, et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999; 91:465-9.
26. Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003; 187:1780-5.
27. Mbulaiteye SM, Pfeiffer RM, Engels EA, et al. Detection of Kaposi's sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 2004; 190:1382-6.
28. Dedicoat M, Newton R, Alkharsah KR, et al. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004; 190:1068-75.
29. Mbulaiteye S, Marshall V, Bagni RK, et al. Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 2006; 193:1250-7.
30. Camera Pierrotti L, Sumita LM, Santos Freire W, Hehl Caiaffa Filho H, de Souza VA. Detection of human herpesvirus 8 DNA and antibodies to latent nuclear and lytic-phase antigens in serial samples from AIDS patients with Kaposi's sarcoma. J Clin Virol 2000; 16:247-51.
31. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of FOCUS ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10:530-6.
32. Nascimento MC, Ferreira S, Sabino E, et al. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinico-virological reference standards in Brazil. J Clin Microbiol 2007; 45: 2309-11.
33. Stebbing J, Bourboulia D, Johnson M, et al. Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. J Virol 2003; 77: 4306-14.
34. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41:95-8.
35. Zong JC, Ciufo DM, Alcendor DJ, et al. High-level variability in the ORF K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999; 73:4156-70.
36. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4:406-25.
37. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001; 17:1244-5.
38. Cook PM, Whitby D, Calabro ML, et al. Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. AIDS 1999; 13:1165-76.
39. Meng YX, Sata T, Stamey FR, et al. Molecular characterization of strains of Human herpesvirus 8 from Japan, Argentina, and Kuwait. J Gen Virol 2001; 82:499-506.
40. Nascimento MC, Wilder N, Pannuti CS, Weiss HA, Mayaud P. Molecular characterization of Kaposi's sarcoma associated herpesvirus (KSHV) from patients with AIDS-associated Kaposi's sarcoma in São Paulo, Brazil. J Clin Virol 2005; 33:52-9.
41. Lacoste V, Judde JG, Briere J, et al. Molecular epidemiology of human herpesvirus 8 in Africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread. Virology 2000; 278:60-74.
42. Fouchard N, Lacoste V, Couppie P, et al. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer 2000; 85:166-70.
43. Cook RD, Hodgson TA, Waugh ACW, et al. Mixed patterns of transmission of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) in Malawian families. J Gen Virol 2002; 83:1613-9.
44. Souza VA, Sumita LM, Freire W, et al. Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in São Paulo State. Braz J Med Biol Res 2004; 37:123-7.
45. Bourboulia D, Whitby D, Boshoff C, et al. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA 1998; 280:31-2.
46. Lyall EG, Patton GS, Sheldon J, et al. Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 1999; 18:795-9.
47. Koelle DM, Huang ML, Chandran B, Vieira J, Piepkorn M, Corey L. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997; 176:94-102.
48. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343:1369-77.
49. Corey L, Brodie S, Huang ML, Koelle DM, Wald A. HHV-8 infection: a model for reactivation and transmission. Rev Med Virol 2002; 12: 47-63.
50. Taylor MM, Chohan B, Lavreys L, et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 2004; 190:484-8.